The first ever over-the-counter version of the opioid overdose reversal drug naloxone was approved by the FDA Wednesday, a move that could dramatically increase access to a life saving medication.
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
In the face of senators' criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company's COVID-19 vaccine in a hearing Wednesday on the vaccine's price.
An appeals court has ruled resoundingly in favor of an Ojai pharmacy and 21 other independent drugstores that claim massive PBM Optum Rx underpays medication reimbursements in an effort to push them out of existence.